Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hormone cytostatic agents

I Könyves

    Scandinavian Journal of Urology and Nephrology. Supplementum
    |January 1, 1980
    PubMed
    Summary

    New antitumour agents using steroids as carriers for cytostatics show promise. Estramustine phosphate and prednimustine demonstrate effectiveness in treating advanced, hormone-resistant cancers.

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Estramustine phosphate (Estracyt) in the treatment of prostatic carcinoma.

    International urology and nephrology·1989
    Same author

    Estramustine phosphate--historical overview.

    Urology·1984
    Same author

    Chemotherapy principles in the treatment of prostatic cancer.

    The Prostate·1984
    Same author

    International overview on the treatment of prostate cancer--Scandinavian experience.

    The Prostate·1984
    Same author

    Phase II study of Leo 1031 (prednimustine) in advanced ovarian carcinoma.

    Cancer treatment reports·1979
    Same author

    Prednimustine in adult acute myeloid leukaemia.

    Cancer chemotherapy and pharmacology·1979

    Area of Science:

    • Oncology
    • Medicinal Chemistry
    • Pharmacology

    Background:

    • Steroids have been explored as carriers for cytostatic drugs.
    • Developing novel antitumour agents is crucial for cancer therapy.

    Purpose of the Study:

    • To synthesize and characterize novel antitumour agents.
    • To evaluate the efficacy of steroid-drug conjugates in cancer treatment.

    Main Methods:

    • Synthesis of steroid-cytostatic conjugates.
    • Chemical and pharmacological property assessment.
    • In vitro and in vivo efficacy studies (implied).

    Main Results:

    • Successful synthesis of novel antitumour agents.
    • Estramustine phosphate and prednimustine exhibit significant antitumour activity.
    • Positive effects observed in advanced hormone-resistant cancer models.

    Conclusions:

    • Steroid-based drug delivery systems offer a viable strategy for cancer therapy.
    • Estramustine phosphate and prednimustine are promising candidates for treating hormone-resistant cancers.